Catalog |
name |
Description |
price |
R-R-2811 |
MK 0893 CAS No.870823-12-4 |
MK 0893/CAS No.870823-12-4 is a potent and selective glucagon receptor antagonist with an IC50 of 6.6 nM. |
price> |
R-R-2812 |
Adomeglivant CAS No.1488363-78-5 |
Adomeglivant (LY2409021)/CAS No.1488363-78-5 is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus. |
price> |
R-R-2813 |
GLP-1(7-37) acetate CAS No.1450806-98-0 |
GLP-1(7-37) acetate/CAS No.1450806-98-0 is an intestinal insulinotropic hormone that augments glucose induced insulin secretion. |
price> |
R-R-2814 |
Semaglutide TFA |
Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment. |
price> |
R-R-2815 |
BETP CAS No.1371569-69-5 |
BETP/CAS No.1371569-69-5 is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively. |
price> |
R-R-2816 |
GLP-1(9-36)amide CAS No.161748-29-4 |
GLP-1(9-36)amide/CAS No.161748-29-4 is a major metabolite of glucagon-like peptide-1-(7-36) amide formed by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP-1(9-36)amide acts as an antagonist to the human pancreatic GLP-1 receptor. |
price> |
R-R-2817 |
GLP-1R Antagonist 1 CAS No.488097-06-9 |
GLP-1R Antagonist 1 (compound 5d)/CAS No.488097-06-9 is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R), with an IC50 of 650 nM. |
price> |
R-R-2818 |
Cotadutide acetate |
Cotadutide (MEDI0382) acetate is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC50 values of 6.9 pM and 10.2 pM, respectively. Cotadutide acetate exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide acetate can be used in the research of obesity and type 2 diabetes (T2D). |
price> |
R-R-2819 |
Beinaglutide CAS No.123475-27-4 |
Beinaglutide/CAS No.123475-27-4 is a human GLP-1 polypeptide that shares almost 100% homology with human GLP-1 (7–36). Beinaglutide displays does-dependent effects in glycemic control, inhibiting food intake and gastric empty and promoting weight loss. Beinaglutide has the potential for the research of overweight/obesity and nonalcoholic steatohepatitis (NASH). |
price> |
R-R-2820 |
GLP-2(1-33)(human) CAS No.223460-79-5 |
GLP-2(1-33) (human)/CAS No.223460-79-5 is an enteroendocrine hormone which can bind to the GLP-2 receptor and stimulate the growth of intestinal epithelium. |
price> |